Schedule 13G ownership disclosure
SILO PHARMA INC COM
Common Stock, par value $0.0001 per share · CUSIP: 82711P201
Event date: 2024-09-04
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Renaissance Technologies LLC
Shares: 227,006 · Class: 5.06%
- Renaissance Technologies Holdings Corporation
Shares: 227,006 · Class: 5.06%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001037389-24-000104
- Form type
- SCHEDULE 13G
- Filer
- RENAISSANCE TECHNOLOGIES LLC
- CIK
- CIK 1037389
- Filed
- Nov 13, 2024
- Reporting period
- Sep 04, 2024
- Description
- Schedule 13G beneficial ownership